David Alland, director of the Public Health Institute at Rutgers New Jersey Medical School, led the research team that assessed a late test prototype.
John Emerson
Researchers are evaluating a test that is fast and easy to perform without the need for a centralized laboratory
the staff of the Ridgewood blog
New Brunswick NJ, A Rutgers research team has completed the first evaluation of a new rapid COVID-19 test given emergency approval by the FDA. The test, developed by CEPHEID, a U.S. molecular diagnostics company, is fast and easy to perform without the need for a centralized laboratory. The company said the test would be available next week.
Continue reading Rutgers Researchers Evaluate New Rapid COVID-19 Test
